Skip to content

Harm-reduction information only — not medical advice. In crisis or experiencing adverse effects, contact a healthcare professional or your local emergency services immediately.

AnabolicDex logo AnabolicDex
Search (no-JS fallback)
Peptides Weight LossMetabolic

Survodutide

Survodu · BI 456906

Investigational dual GLP-1/glucagon receptor agonist for obesity and MASH; weekly injection.

🚧 Expanded guide coming soon. This compound has PK data and a source — a full overview, mechanism, and dosing guide is pending editorial review.

Pharmacokinetic summary

Model tier
Simple (t½ + F, Tmax estimated)
Half-life
6 days
Bioavailability
80%
Typical dose
0.72–9.6 mg

Related compounds

Mazdutide

GLP-1/glucagon dual agonist; long half-life, weekly dosing.

Semaglutide Injection (Ozempic/Wegovy)

Long-acting GLP-1 receptor agonist for type 2 diabetes and weight loss; weekly injection.

Semaglutide Oral (Rybelsus)

Oral semaglutide with very low bioavailability; taken fasting.

Comments

Loading comments…